Skip to main content
. 2013 Sep 15;1(1):51–58. doi: 10.14218/JCTH.2013.00006

Figure 6. Cumulative probability of entecavir resistance (rtT184, rtS202, or rtM250) in the presence of lamivudine-resistance mutations (rtM204 and rtL180M) among nucleoside-naive hepatis Be antigen (HBeAg)-positive and HBeAg-negative patients during 6 years of treatment.

Figure 6